Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

QLT settles Eligard patent dispute; pay-out is $157.5mm

Executive Summary

QLT Inc. (ophthalmology, urology, and dermatology treatments) and its QLT USA subsidiary (formerly Atrix Laboratories) have reached an agreement with TAP Pharmaceutical Products, Takeda Chemical, and Wako Pure Chemical regarding potential patent infringement.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register